Pharmacokinetic variability between and within patients using cenobamate in clinical practice

被引：0
|
作者：
Gottas, A. [1 ]
Kjeldsen, S. F. [1 ]
Listhaug, C. [1 ]
Awad, L. [2 ]
Burns, M. L. [1 ]
Johannessen, S. I. [1 ,3 ]
Landmark, C. Johannessen [1 ,2 ,3 ]
机构：
[1] Oslo Univ Hosp, Sect Clin Pharmacol, Dept Pharmacol, Sandvika, Norway
[2] Oslo Metropolitan Univ, Dept Pharm, Fac Hlth Sci, Oslo, Norway
[3] Oslo Univ Hosp, Natl Ctr Epilepsy, Member ERN EpiCare, Sandvika, Norway
来源：
EPILEPSIA | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1288
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [21] High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
    Anouk M. E. Jansen
    Rob ter Heine
    Paul E. Verweij
    Roger J. M. Brüggemann
    Clinical Pharmacokinetics, 2023, 62 : 1695 - 1699
  • [22] High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints
    Jansen, Anouk M. E.
    ter Heine, Rob
    Verweij, Paul E.
    Brueggemann, Roger J. M.
    CLINICAL PHARMACOKINETICS, 2023,
  • [23] Pharmacokinetic studies in patients with inherited bleeding disorders - challenges and relevance to clinical practice
    Lee, C. A.
    HAEMOPHILIA, 2006, 12 : 1 - 2
  • [24] Formulation substitution and other pharmacokinetic variability: Underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice
    Reiffel, JA
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (10A) : 46D - 52D
  • [25] Screening of hypertension. Variability between clinical practice and current recommendations
    Perez-Manchon, D.
    Plaza-Rivera, S.
    HIPERTENSION Y RIESGO VASCULAR, 2020, 37 (01): : 45 - 47
  • [26] Variability, regulation and clinical practice
    Goodyear-Smith, Felicity
    JOURNAL OF PRIMARY HEALTH CARE, 2014, 6 (02) : 90 - 91
  • [27] Pharmacodynamic and Pharmacokinetic Properties of EnoxaparinImplications for Clinical Practice
    Jawed Fareed
    Debra Hoppensteadt
    Jeanine Walenga
    Omer Iqbal
    Qing Ma
    Walter Jeske
    Taqdees Sheikh
    Clinical Pharmacokinetics, 2003, 42 : 1043 - 1057
  • [28] Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations
    Karine Lecointre
    Laurence Pisanté
    Francis Fauvelle
    Serge Mazouz
    Clinical Drug Investigation, 2001, 21 : 225 - 232
  • [29] Nanocarriers in cancer clinical practice: a pharmacokinetic issue
    Giodini, Luciana
    Lo Re, Francesco
    Campagnol, Davide
    Marangon, Elena
    Posocco, Bianca
    Dreussi, Eva
    Toffoli, Giuseppe
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (02) : 583 - 599
  • [30] Relationship between pharmacokinetic (PK) sampling schema and reported PK variability of liposomes in patients
    Schell, Ryan F.
    Caron, Whitney P.
    Walsh, Mark D.
    Zamboni, Beth A.
    Ramanathan, Ramesh K.
    Zamboni, William C.
    CANCER RESEARCH, 2011, 71
12345